Active substance
Milrinone
- SFDA 3
- US FDA 30
- Health Canada 2
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| Milrinone BOS | 1 mg/ml | Solution for injection · Intravenous use | 10 Vial | SAR 786.50 | NCE · Prescription | Boston Oncology Arabia | Valid |
| Primalon | 1 mg/ml | Solution for injection · Intravenous use | 10 Vial | SAR 707.85 | Generic · Prescription | Jazeera Pharmaceutical Industries (JPI) | Valid |
| RINOMEL | 1 mg/ml | Solution for injection/infusion · Intravenous use | 10 Vial | SAR 747.15 | Generic · Prescription | ALPHA PHARMA INDUSTRY | Valid |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| MILRINONE LACTATE | EQ 1MG BASE/ML; EQ 20MG /20ML (1MG/ML); EQ 50MG /50ML (1MG/ML) | injectable · injection | HIKMA PHARMS | Prescription | 28 May 2002 |
| MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER | EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML); EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML) | injectable · injection | BAXTER HLTHCARE | Prescription | 28 May 2002 |
| MILRINONE LACTATE | EQ 1MG BASE/ML | injectable · injection | FRESENIUS KABI USA | Prescription | 28 May 2002 |
| MILRINONE LACTATE | 20MG/20ML | injectable · injection | BAXTER HLTHCARE CORP | Prescription | 21 Sep 2004 |
| MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER | EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML); EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML) | injectable · injection | HIKMA PHARMS | Prescription | 21 May 2008 |
| MILRINONE LACTATE IN PLASTIC CONTAINER | EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML); EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML) | injectable · injection | HIKMA FARMACEUTICA | Prescription | 21 Jan 2010 |
| MILRINONE LACTATE | EQ 1MG BASE/ML | injectable · injection | HIKMA FARMACEUTICA | Prescription | 3 Dec 2010 |
| MILRINONE LACTATE | EQ 1MG BASE/ML | injectable · injection | HOSPIRA | Prescription | 3 Sep 2014 |
| MILRINONE LACTATE | EQ 1MG BASE/ML | injectable · injection | MEITHEAL | Prescription | 24 Mar 2020 |
| MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER | EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML); EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML) | injectable · injection | GLAND | Prescription | 16 Jul 2020 |
| MILRINONE LACTATE IN DEXTROSE 5% | EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML); EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML) | injectable · injection | EUGIA PHARMA | Prescription | 3 Sep 2020 |
| MILRINONE LACTATE | EQ 1MG BASE/ML | injectable · injection | CAPLIN | Prescription | 16 Apr 2021 |
| MILRINONE LACTATE | EQ 1MG BASE/ML | injectable · injection | SHANDONG | Prescription | 23 Jan 2023 |
| MILRINONE LACTATE IN DEXTROSE 5% | EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML); EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML) | injectable · injection | CAPLIN | Prescription | 2 Sep 2025 |
| PRIMACOR | EQ 1MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | injectable · injection | SANOFI AVENTIS US | Discontinued | 31 Dec 1987 |
| PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER | EQ 10MG BASE/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; EQ 15MG BASE/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | injectable · injection | SANOFI AVENTIS US | Discontinued | 9 Aug 1994 |
| MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER | EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) | injectable · injection | HIKMA PHARMS | Discontinued | 28 May 2002 |
| MILRINONE LACTATE | EQ 1MG BASE/ML | injectable · injection | HIKMA PHARMS | Discontinued | 28 May 2002 |
| MILRINONE LACTATE | EQ 1MG BASE/ML | injectable · injection | HOSPIRA | Discontinued | 28 May 2002 |
| MILRINONE LACTATE | EQ 1MG BASE/ML | injectable · injection | HIKMA PHARMS | Discontinued | 28 May 2002 |
| MILRINONE LACTATE | EQ 1MG BASE/ML | injectable · injection | HOSPIRA | Discontinued | 28 May 2002 |
| MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER | EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML); EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML) | injectable · injection | HOSPIRA | Discontinued | 28 May 2002 |
| MILRINONE LACTATE | EQ 1MG BASE/ML | injectable · injection | INTL MEDICATED | Discontinued | 2 Aug 2002 |
| MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER | EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) | injectable · injection | BAXTER HLTHCARE | Discontinued | 8 Aug 2002 |
| MILRINONE LACTATE | EQ 1MG BASE/ML | injectable · injection | MYLAN INSTITUTIONAL | Discontinued | 16 Jun 2003 |
5 more — full table
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| MILRINONE LACTATE INJECTION USP | 02521407 | 1 MG / ML | SOLUTION · INTRAVENOUS | MARCAN PHARMACEUTICALS INC |
| MILRINONE LACTATE INJECTION, USP | 02244622 | 1 MG / ML | SOLUTION · INTRAVENOUS | FRESENIUS KABI CANADA LTD |
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.